Renal disorders in Autoimmune Polyendocrinopathy Candidiasis Ectodermal dystrophy (APECED): a systematic review
- PMID: 40000975
- PMCID: PMC11863426
- DOI: 10.1186/s12887-025-05458-2
Renal disorders in Autoimmune Polyendocrinopathy Candidiasis Ectodermal dystrophy (APECED): a systematic review
Abstract
Background: Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED), also known as autoimmune polyendocrine syndrome type I (APS-I) is an inborn error of immunity (IEI) with an immune dysregulation phenotype, mainly characterized by endocrine and non-endocrine manifestations including adrenal insufficiency, chronic mucocutaneous candidiasis, and ectodermal dystrophy. Renal disorders seem to be a significant morbidity in APECED patients, requiring further investigations.
Methods: The literature search was conducted in PubMed, Web of Science, and Scopus databases using relevant keywords, and included articles were systematically reviewed regarding the clinical and immunological features. APECED patients with at least one nephrological complication were included.
Results: Ninety-three APECED patients from 30 studies were identified. More than half of the patients (38,52%) presented nephrocalcinosis. The second and third most prevalent renal complications were tubulointerstitial nephritis (TIN) (23,31%), and hypertension (13,18%), respectively. Other less frequent renal disorders including renal tubular acidosis (RTA) glomerulonephritis were also reported among patients. Additionally urinary tract infections (UTI), were also common among cases (15,20.5%).
Conclusions: Renal complications in APECED represent a significant issue that should be monitored and considered in managing these patients to preserve renal function and improve patients' outcomes.
Keywords: AIRE; APECED; Autoimmune polyendocrinopathy; Inborn error of immunity; Nephrocalcinosis; Primary immunodeficiency.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Kidney involvement in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in a Finnish cohort.Nephrol Dial Transplant. 2014 Sep;29(9):1750-7. doi: 10.1093/ndt/gfu064. Epub 2014 Apr 7. Nephrol Dial Transplant. 2014. PMID: 24711434
-
Clinical, immunological, and genetic features in 938 patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a systematic review.Expert Rev Clin Immunol. 2021 Aug;17(8):807-817. doi: 10.1080/1744666X.2021.1925543. Epub 2021 Jun 3. Expert Rev Clin Immunol. 2021. PMID: 33957837
-
Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome.Br J Dermatol. 2006 Jun;154(6):1088-93. doi: 10.1111/j.1365-2133.2006.07166.x. Br J Dermatol. 2006. PMID: 16704638
-
Delay in the Diagnosis of APECED: A Case Report and Review of Literature from Iran.Immunol Invest. 2020 Apr;49(3):299-306. doi: 10.1080/08820139.2019.1671451. Epub 2019 Oct 7. Immunol Invest. 2020. PMID: 31588815 Review.
-
Childhood Polyarthritis As Early Manifestation of Autoimmune Polyendocrinopathy with Candidiasis and Ectodermal Dystrophy Syndrome.Front Immunol. 2017 Apr 18;8:377. doi: 10.3389/fimmu.2017.00377. eCollection 2017. Front Immunol. 2017. PMID: 28458664 Free PMC article.
Cited by
-
Research progress in abnormal carbohydrate, lipid, and protein metabolism in children with isolated growth hormone deficiency.Front Endocrinol (Lausanne). 2025 May 22;16:1553008. doi: 10.3389/fendo.2025.1553008. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40475996 Free PMC article. Review.
References
-
- Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab. 2006;91(8):2843–50. - PubMed
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous